The ends of a conundrum?
Paramio
Jesús M
JM
Santos
Mirentxu
M
Jorcano
José L
JL
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000633:toxicity; D000818:Animals; D017209:Apoptosis; D001665:Binding Sites; D002273:Carcinogens / Q000633:toxicity; D049109:Cell Proliferation; D002478:Cells, Cultured; D004198:Disease Susceptibility / Q000378:metabolism / Q000503:physiopathology; D000078404:Epidermal Cells; D007382:Intermediate Filaments / Q000378:metabolism; D053550:Keratin-10 / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D053547:Keratin-14 / Q000737:chemistry / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D053555:Keratin-5 / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D015603:Keratinocytes / Q000166:cytology / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D018345:Mice, Knockout; D008822:Mice, Transgenic; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D012878:Skin Neoplasms / Q000209:etiology / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology; D013755:Tetradecanoylphorbol Acetate / Q000633:toxicity
D002273:Carcinogens; D053547:Keratin-14; D053555:Keratin-5; D053550:Keratin-10; D015127:9,10-Dimethyl-1,2-benzanthracene; D013755:Tetradecanoylphorbol Acetate